LYZ and diabetic kidney disease: LYZ is a plasma biomarker of atherosclerosis [31], and LYZ is associated with vascular-related diseases, including hypertension, diabetic nephropathy, and abdominal aortic aneurysm, with significantly elevated LYZ expression in peripheral blood and other tissues [32].